Results 111 to 120 of about 2,490 (187)
MODELLING GBA1-RELATED PARKINSON¿S DISEASE PATHOLOGY IN PATIENT-DERIVED MIDBRAIN ORGANOIDS
Aggregation of α-synuclein protein in “Lewy bodies” and “Lewy neurites” and dopaminergic neuronal loss in the nigrostriatal system are the key neuropathological hallmarks of Parkinson’s disease.
FRATTINI, EMANUELE
core
Medical Literature in the Age of Artificial Intelligence
iNew Medicine, Volume 2, Issue 2, June 2026.
Hunter Scott
wiley +1 more source
Macitentan in the treatment of pulmonary hypertension in Gaucher‚s disease. [PDF]
Taylan G +3 more
europepmc +1 more source
Gaucher’s disease (GD) has variable presentations, but cardiac involvement is a generally uncommon clinical manifestation of the disease. In the past 25 years, the underlying genetic disorder in GD has been well characterized, with almost 300 mutations ...
Kardum-Skelin, Ika +11 more
core
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease. The development of PD is closely linked to genetic and environmental factors, with GBA1 variants being the most common genetic risk.
Xuxiang Zhang +3 more
doaj +1 more source
The Impact of Provider Choice on Workers' Compensation Costs and Outcomes [PDF]
We study how provider choice in workers' compensation cases affects costs and outcomes. When employees choose the provider, costs are higher and return-to-work outcomes are worse, while physical recovery is the same although satisfaction with medical ...
Peter S. Barth +2 more
core
Identification of risk features for complication in Gaucher's disease patients: a machine learning analysis of the Spanish registry of Gaucher disease. [PDF]
Andrade-Campos MM +9 more
europepmc +1 more source
Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 10, Issue S1, June 2026.
wiley +1 more source
Beta Thalassemia Major with Gaucher's Disease: A Rare Entity. [PDF]
Bai N +4 more
europepmc +1 more source

